Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products.
第一作者:
Nerea,Varo
第一单位:
Donald W Reynolds Cardiovascular Clinical Research Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
作者:
主题词
动物(Animals);动脉粥样硬化(Atherosclerosis);血小板(Blood Platelets);CD40配体(CD40 Ligand);细胞, 培养的(Cells, Cultured);趋化因子CCL5(Chemokine CCL5);糖尿病, 2型(Diabetes Mellitus, Type 2);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);葡萄糖(Glucose);人类(Humans);男(雄)性(Male);小鼠(Mice);P选择素(P-Selectin);血小板活化(Platelet Activation);血小板源性生长因子(Platelet-Derived Growth Factor);重组蛋白质类(Recombinant Proteins);T淋巴细胞(T-Lymphocytes);凝血酶(Thrombin)
DOI
10.3132/dvdr.2005.014
PMID
16308911
发布时间
2017-11-16
- 浏览16
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文